Product Program year 2025 Source: CMS Open Payments

Sohonos

Drug Rare Disease

NDC 15054-0050-1

Open in the dashboard

General payments

$34,893

101 payments

Research payments

$0

0 payments

Through program year 2025, $34,893 in general payments and $0 in research payments were reported against Sohonos (Rare Disease).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $19,051 9
2024 General $14,776 49
2023 General $1,067 43

Breakdown

Who paid General payments · program years 2023–2025
  1. Ipsen Biopharmaceuticals, Inc $34,893 101 payments
Top recipients General payments · program year 2025
  1. Robert Pignolo Internal Medicine · Rochester, MN $13,358 70% · 4 payments
  2. Kristen Lancaster Clinical Genetics (M.D.) · Charleston, SC $1,950 10% · 1 payment
  3. Matthew Drake Endocrinology, Diabetes & Metabolism · Rochester, MN $1,568 8% · 2 payments
  4. Saima Ali Nurse Practitioner · Houston, TX $1,200 6% · 1 payment
  5. Richard Newport Physician Assistant · Abilene, TX $975 5% · 1 payment

Each share is of general payments naming this product in 2025.

Specialties paid General payments · program year 2025
  1. Internal Medicine $13,358 70% · 1 practitioner
  2. Clinical Genetics (M.D.) Medical Genetics $1,950 10% · 1 practitioner
  3. Endocrinology, Diabetes & Metabolism Internal Medicine $1,568 8% · 1 practitioner
  4. Nurse Practitioner $1,200 6% · 1 practitioner
  5. Physician Assistant $975 5% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Minnesota $14,926 78% · 2 recipients
  2. Texas $2,175 11% · 2 recipients
  3. South Carolina $1,950 10% · 1 recipient

Each share is of general payments naming this product in 2025 where a state was reported.

101 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record